Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

NCT05317858

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, +15 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Miami Cancer Institute at Baptist Health Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 67 locations
View Trial Details
Recruiting

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07154290

Conditions
Advanced/Metastatic Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Cancer Treatment Centers of America, Phoenix Goodyear, Arizona, United States
  • The City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Illinois Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06179160

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • Sarah Cannon Research Institue At Healthone Denver, Colorado, United States
View all 34 locations
View Trial Details
Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States
  • St. Jude Heritage Medical Group - Fullerton Plaza Multi-Specialty Clinic (Pulmonary Function Test) Fullerton, California, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
View all 372 locations
View Trial Details
Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

NCT06767514

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Study Site Chandler, Arizona, United States
  • Clinical Study Site Phoenix, Arizona, United States
  • Clinical Study Site Hot Springs, Arkansas, United States
  • Clinical Study Sites Jonesboro, Arkansas, United States
View all 270 locations
View Trial Details
Recruiting

Using Urine Samples to Identify Lung Cancer

NCT06033248

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

NCT06996782

Conditions
Advanced or Metastatic Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Baltimore, Maryland, United States
View all 103 locations
View Trial Details
Recruiting

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

NCT05098132

Conditions
1st Line NSCLC, Advanced Solid Tumor, Bronchial Neoplasms, +11 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 47 locations
View Trial Details
Recruiting

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

NCT06899126

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Orange Coast Memorial Medical Center Fountain Valley Fountain Valley, California, United States
  • California Research Institute Los Angeles, California, United States
  • Los Angeles Cancer Network (LACN) Los Angeles, California, United States
View all 237 locations
View Trial Details

Related conditions